MetaADEDB 2.0 @ LMMD
cevimeline
(ZSTLCHCDLIUXJE-UHFFFAOYSA-N)
Structure
SMILES
CC1SCC2(O1)CN1CCC2CC1.CC1SCC2(O1)CN1CCC2CC1.O.Cl.Cl
Molecular Formula:
C20H38Cl2N2O3S2
Molecular Weight:
489.563
Log P:
4.5359
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
84.77
CAS Number(s):
153504-70-2
Synonym(s)
1.
cevimeline
2.
2-methyspiro(1,3-oxathiolane-5,3)quinuclidine
3.
AF 102B
4.
AF 102B, (cis-(+))-isomer
5.
AF 102B, (trans)-isomer
6.
AF-102B
7.
AF102B
8.
Evoxac
9.
FKS 508
10.
FKS-508
11.
SNI 2011
12.
SNI-2011
13.
cevimeline hydrochloride
External Link(s)
MeSHC059240
PubChem Compound92031109
6850802
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Unevaluable eventFAERS: 22US FAERS
2Drug ineffectiveFAERS: 19US FAERS
3MalaiseFAERS: 6US FAERS
4DehydrationFAERS: 4US FAERS
5No adverse eventFAERS: 4US FAERS
6NauseaFAERS: 3US FAERS
7Blood creatine phosphokinase increasedFAERS: 2US FAERS
8Blood creatinine increasedFAERS: 2US FAERS
9Depressed Level of ConsciousnessFAERS: 2US FAERS
10Incorrect dose administeredFAERS: 2US FAERS
11OliguriaFAERS: 2US FAERS
12Pneumatosis intestinalisFAERS: 2US FAERS
13AlopeciaFAERS: 1US FAERS
14Altered visual depth perceptionFAERS: 1US FAERS
15Angle Closure GlaucomaFAERS: 1US FAERS
16AnxietyFAERS: 1US FAERS
17AstheniaFAERS: 1US FAERS
18Atrial FibrillationFAERS: 1US FAERS
19Atrioventricular BlockFAERS: 1US FAERS
20BlindnessFAERS: 1US FAERS
21CholelithiasisFAERS: 1US FAERS
22ChoreaFAERS: 1US FAERS
23ChromaturiaFAERS: 1US FAERS
24CryingFAERS: 1US FAERS
25DiscomfortFAERS: 1US FAERS
26DizzinessFAERS: 1US FAERS
27Drug dose omissionFAERS: 1US FAERS
28Economic problemFAERS: 1US FAERS
29Eye painFAERS: 1US FAERS
30Eye prosthesis insertionFAERS: 1US FAERS
31FlushingFAERS: 1US FAERS
32HeadacheFAERS: 1US FAERS
33HypotensionFAERS: 1US FAERS
34IncoherentFAERS: 1US FAERS
35InflammationFAERS: 1US FAERS
36Musculoskeletal PainFAERS: 1US FAERS
37MyalgiaFAERS: 1US FAERS
38Neck PainFAERS: 1US FAERS
39NeuralgiaFAERS: 1US FAERS
40NocturiaFAERS: 1US FAERS
41Ocular RosaceaFAERS: 1US FAERS
42ParotitisFAERS: 1US FAERS
43Poor quality sleepFAERS: 1US FAERS
44Product administration errorFAERS: 1US FAERS
45Product substitution issueFAERS: 1US FAERS
46Quality of life decreasedFAERS: 1US FAERS
47Rash erythematousFAERS: 1US FAERS
48Saliva alteredFAERS: 1US FAERS
49Septic ShockFAERS: 1US FAERS
50Sjogren's SyndromeFAERS: 1US FAERS
51Stevens-Johnson SyndromeFAERS: 1US FAERS
52StomatitisFAERS: 1US FAERS
53SyncopeFAERS: 1US FAERS
54Terminal stateFAERS: 1US FAERS
55ThirstFAERS: 1US FAERS
56ToothacheFAERS: 1US FAERS
57Transaminases increasedFAERS: 1US FAERS
58TremorFAERS: 1US FAERS
59Urinary IncontinenceFAERS: 1US FAERS
60VomitingFAERS: 1US FAERS
61nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.